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Abstract
Background: The use of rapid diagnostic tests (RDTs) for Plasmodium falciparum malaria is being suggested to improve
diagnostic efficiency in peripheral health care settings in Africa. Such improved diagnostics are critical to minimize overuse
and thereby delay development of resistance to artemisinin-based combination therapies (ACTs). Our objective was to
study the influence of RDT-aided malaria diagnosis on drug prescriptions, health outcomes, and costs in primary health care
settings.
Methods and Findings: We conducted a cross-over validation clinical trial in four primary health care units in Zanzibar.
Patients of all ages with reported fever in the previous 48 hours were eligible and allocated alternate weeks to RDT-aided
malaria diagnosis or symptom-based clinical diagnosis (CD) alone. Follow-up was 14 days. ACT was to be prescribed to
patients diagnosed with malaria in both groups. Statistical analyses with multilevel modelling were performed. A total of
1,887 patients were enrolled February through August 2005. RDT was associated with lower prescription rates of
antimalarial treatment than CD alone, 361/1005 (36%) compared with 752/882 (85%) (odds ratio [OR] 0.04, 95% confidence
interval [CI] 0.03–0.05, p,0.001). Prescriptions of antibiotics were higher after RDT than CD alone, i.e., 372/1005 (37%) and
235/882 (27%) (OR 1.8, 95%CI 1.5–2.2, p,0.001), respectively. Reattendance due to perceived unsuccessful clinical cure was
lower after RDT 25/1005 (2.5%), than CD alone 43/882 (4.9%) (OR 0.5, 95% CI 0.3–0.9, p=0.005). Total average cost per
patient was similar: USD 2.47 and 2.37 after RDT and CD alone, respectively.
Conclusions: RDTs resulted in improved adequate treatment and health outcomes without increased cost per patient. RDTs
may represent a tool for improved management of patients with fever in peripheral health care settings.
Trial Registration: Clinicaltrials.gov NCT00549003
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Morbidity and mortality due to Plasmodium falciparum malaria
have been increasing in sub-Saharan Africa since the early 1990s,
concomitantly with spread of resistance to commonly used
monotherapies, i.e., chloroquine and sulfadoxine-pyrimethamine
[1,2]. This increased resistance has necessitated that many African
countries change their treatment policy to artemisinin-based
combination therapy (ACT) as a first-line treatment for uncom-
plicated malaria. The restricted use of ACT to confirmed malaria
patients is critical. Overuse of the more expensive ACTs will not
only put an extra heavy financial burden on malaria control
programmes in Africa, but also enhance drug resistance and
prevent other causes of fever from being appropriately treated, for
example, pneumonias, which require antibiotics.
Symptom-based or clinical malaria diagnosis has proven to be
quite unspecific [3–7]. Malaria diagnosis based on parasitological
confirmation is therefore increasingly advocated. Integrated Man-
agement of Childhood Illness (IMCI) algorithms based on clinical
symptoms could potentially be made more efficient and cost-
effective if simple parasitological diagnostic methodologies were
incorporated. The use ofmicroscopyhas been tried invarious health
care settings, but is associated with problems of logistics, sustain-
ability, and quality control [8,9]. The development of rapid
diagnostic tests (RDTs) for P. falciparum malaria offers a potential
alternative in remote and poorly resourced health facilities that are
beyond the reach of high-quality microscopy services [10–14]. The
combination of RDT and ACT provides an important strategic
opportunity to reduce malaria-associated mortality in Africa, and
RDT use will potentially improve treatment of other causes of fever,
for example, life-threatening bacterial diseases [15,16]. However,
the evidence base is still inadequate for malaria control programmes
to recommend the use of RDTs on a large scale. There are several
studies on sensitivities and specificities of various malaria diagnostic
methods [11–14,16–19]. In two recently published studies on the
implication of RDT use at the health facility level on drug
prescription, both describe major problems with test efficiency
when used in clinical practice [15,20]. However, this may be
attributed to different messages regarding the risk of withholding
malaria treatment to patients with negative test results [21]. Also,
these studies did not describe staff training on technique and
validation of RDTs, a prerequisite for the malaria diagnostic tests to
become cost effective [22]. Furthermore, and importantly, there are
no randomized control trials on the health impact and cost-
effectiveness of confirmatory malaria diagnosis based on RDTs [18].
Zanzibar was among the first regions in sub-Saharan Africa to
introduce ACT, free of charge through public health care, as both as
first- and second- line treatment for uncomplicated malaria, which
are provided free of charge through public health care. In view of the
fact that many patients with fever are prescribed ACT without being
malaria infected, the present study was undertaken to assess, on a
wide scale, the added value of RDT to clinical diagnosis (CD) alone
for management of patients of all ages presenting with fever at
primary health care facilities. The hypothesis was that RDT-aided
diagnosis of fever patients would improve rational use of ACTs and
possibly other necessary treatments, such as antibiotics to non-
malaria patients, with an overall improved health impact.
Material and Methods
Study Area and Study Health Centres
The trial was conducted in four Primary Health Care Units
(PHCUs) in Zanzibar, namely, Muyuni and Uzini on Unguja
Island, and Kinyasini and Mzambarauni on Pemba Island. The
selection of the four study sites aimed to provide a representative
picture of Zanzibar with regard to malaria epidemiology as well as
previous use of RDT in Zanzibar. By the time of the trial, malaria
transmission in Zanzibar was generally considered endemic [23],
with recorded malaria parasite rates between 10% and 50% in
different age groups (unpublished data, Zanzibar Ministry of
Health). A previous clinical trial conducted in two comparable
PHCUs had shown an overall malaria parasite prevalence of
about 30% among febrile children aged ,5 y [24]. Two PHCUs
(Muyuni and Mzambarauni) had been trained in and used RDT
for malaria diagnosis 1 y before the study, as part of a Me ´decins
Sans Frontie `res–supported programme in several districts of
Zanzibar; the other two PHCUs (Uzini and Kinyasini) had, up
to the time of the study, provided malaria treatment based on CD
only. Beside that there were no differences in staffing or general
health care capacity between the four PHCUs and they were all
considered representative of rural PHCUs in Zanzibar. Because of
possible heterogeneity among PHCUs statistical multilevel meth-
ods were used in the analyses. Further, to reduce the potential bias
on the patient level a cross-over design was introduced within each
PHCU.
Pre-study Training of Nurses
As in other PHCUs in Zanzibar, registered nurses, with 3 to 4 y
of formal training, were responsible for providing out-patients care
in all study sites. All nurses involved in the study had previously
been trained in malaria case management, i.e., diagnosis and
treatment including the IMCI algorithm, by Malaria Control
Programme and District Health Management Teams of Ministry
of Health. In addition and prior to the study start the staff
members of all four health facilities received a one-day training on
the use of RDTs according to the manufacturer’s instructions.
This training covered performance of the test and interpretation of
the result. Specific instructions were also given to the nurses to
consider other treatments and referral especially in children with
RDT-negative results and to encourage their guardians or mothers
to come back with their children if fever persisted or condition
deteriorated. The study design was described in detail to the staff.
The nurses were responsible for study implementation. The nurses
received a salary supplementation of Tanzanian Shillings (TSh)
25,000 (equivalent of USD 23) per study week. Their ordinary
salary was equivalent to about USD 136 at the time of the trial.
Study Design
This was a nonrandomized four-centre clinical trial but with
weekly cross-over validation comparing CD plus RDT (CD+RDT)
versus CD alone. Each health facility alternately used CD+RDT
or CD alone on a weekly basis. Two sites were allocated to
CD+RDT the first week of the trial and the other two to CD
alone. During the CD-alone weeks RDTs were not to be used.
During RDT weeks the study nurses were encouraged to give
antimalarial treatment based on the RDT results, i.e., to prescribe
ACT only to RDT-positive patients. They were visited by a
member of the research team at least once weekly.
The study was conducted in accordance with Good Clinical
Practice [25] and and the Zanzibar Health Research Council
declared the work as part of malaria control interventions and
polices in Zanzibar. Informed consent was obtained from
participants or parents/legal guardians of enrolled children. The
study is registered at http://www.clinical.trials.gov with study
identification NCT00549003.
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The study was conducted during two periods in 2005: 15
February to 15 April, and 30 May to 10 August. These periods
thus included both low and peak seasons for malaria transmission
in Zanzibar. All patients of all ages with a past history of fever
within last 48 h and symptoms compatible with uncomplicated
malaria were eligible and screened for the study. Other inclusion
criteria included provision of informed consent and living within
the catchments area of the health facility. Patients were not
enrolled if previously included in the study or if the study nurse
was not present at the health facility at the time of attendance.
Treatment of uncomplicated malaria was prescribed according
to national policy in Zanzibar: artesunate with amodiaquine as
first-line treatment and artemether with lumefantrine as second-
line treatment. Drug intake was unsupervised. Patients with severe
manifestations of malaria or any other danger signs were required
to be referred to the next level of care for further treatment. Study
nurses were required to prescribe other treatments in accordance
with the IMCI guidelines and their general clinical judgement.
Patient Follow-up
All enrolled patients were issued a prescription book in which
clinical findings and prescribed medications were to be recorded
during a 14-d follow-up.
Patients were instructed to return for assessment at any time if
symptoms persisted or deteriorated, but also if symptoms recurred
during the 14-d follow-up period. All patients were also asked to
report back to the health facility routinely 14 d after enrolment.
Patients were to be actively followed up if they did not report back
within 14+2 d. Upon the study completion, each participant then
received one insecticide-treated net free of charge.
If a patient made an unscheduled visit between days 1 through
13 due to fever, the study nurse was to prescribe new treatment(s)
based on the diagnostic tool available (CD+RDT or CD alone) at
time of reattendance or to refer the patient. Patients developing
symptoms of severe malaria were to be referred to the next level of
health care. On the scheduled day 14 follow-up visit, patients were
asked to report their perceived health status and intake of any
concomitant medicines during follow-up. Concomitant medica-
tions were to be recorded in the patient case record form,
regardless of whether the patient returned to the health facility of
enrolment or attended any other health facility.
Malaria Diagnosis
CD of uncomplicated malaria was generally based on presence
or history of fever and absence of clear symptoms indicating
alternative causes of fever, e.g., otitis, acute respiratory tract
infection, etc. For children below age 5 y, CD was based on the
IMCI algorithm. We used a histidine-rich protein (HRP) 2 based
test, Paracheck Pf (Orchid Biomedical Systems, India), as RDT.
The RDT result was provided to the patient in support of the
treatment prescribed.
Thick blood smears (BSs) were collected from all patients at
enrolment, on the scheduled day 14 follow-up visit, and at any
unscheduled reattendance at the health facility during follow-up
days 1 through 13. All BSs were brought to a central laboratory
and independently examined by two qualified microscopists,
reader 1 (R1) and reader 2 (R2), after staining with 3% Giemsa
according to standard procedures [26]. Parasite density per
microlitre (ml) of blood of positive BSs was estimated by counting
asexual malaria parasites against 200 to 500 white blood cells
(WBCs), assuming a presence of 8,000 WBCs per ml of blood [26].
A total number of 100 high-power microscope fields were
examined before concluding a negative BS. Discordant BS results
between R1 and R2, i.e., positive versus negative or with more
than 50% difference in parasite densities, were subjected to
examination by a third reader (R3). In the analyses, parasite
presence and geometrical mean (GM) densities were based on R1
and R2 readings for concordant slides, and on the two most similar
readings for discordant slides. Results of the enrolment BS were
routinely provided to the patients on the day 14 follow-up visit, or
at reattendance due to other illness.
Statistical Analyses
According to initial sample size calculations, a total of 850
participants were needed to identify an assumed reduction in
malaria diagnosis of 50% with the addition of RDT to clinical
diagnosis, at a 5% significance level and a power of 80%, without
controlling for design effect of clustering within PHCUs. However,
during the initiation of the trial the Ministry of Health and Social
Welfare requested that the study be powered also for secondary
outcomes. A higher number of participants were thus included in
the trial, i.e., up to 1,887. The design effect was not initially
accounted for in the power calculation but was accounted for in
the final statistical analyses by multilevel modelling. Multilevel
analysis with regard to weeks was not applied since observed slight
seasonal variation is not based on weekly differences.
Patient data were recorded in case report forms. The final BS, see
above, was regarded as the gold standard in the analyses of sensitivity
and specificity for the respective diagnostic procedures. Data were
entered in MicrosoftExcel and analyzed in Epi Infoversion 3.3.2 and
Stata 10. Two-level models with sites (PHCUs) as second level
clustering were applied. Odds ratios (ORs) with 95% CIs and
associated Chi-square tests and p-values (two-sided) were calculated,
where applicable. Statistical significance was defined as p,0.05.
Results
A total of 9,346 patients attended the four health facilities
during the study. There was no significant difference in rate of
fever among patients attending during the first and second
substudy period, i.e. 1,587/4,177 (38%) and 2,108/5,169 (41%),
respectively. Of these 3,695 fever patients a total of 1,887 met the
inclusion criteria (Figure 1), of whom 1,047 (55%) were children
below age 5 y. The main reasons for exclusion were long distance
to health facility, previously included in the study, or study nurse
not present at the time of attendance.
A total of 1,005 and 882 patients were allocated to the
CD+RDT and CD-alone group, respectively. There was a
balanced enrolment rate among the four health facilities (range
424 to 528 patients per site). There was a tendency for the number
of patients enrolled per week to increase with time, i.e., in parallel
with the seasonal increase of malaria transmission during the
second study period. However, no systematic difference in patient
attendance or enrolment was found between CD+RDT and CD-
alone weeks. The study period included an additional CD+RDT
week in two health facilities, explaining the higher overall number
of patients enrolled in the CD+RDT group. Baseline character-
istics (age, sex, number of severe malaria manifestations) were
similar in the two study arms (unpublished data). Parasite
prevalences were also similar—305/1005 (30%) and 247/882
(28%)—as were mean parasite densities (unpublished data) in the
CD+RDT and CD alone groups, respectively.
Diagnostic outcomes, microscopy results, and distribution of
antimalarial treatments in the respective arms, and overall
microscopy results by age group, are presented in Table 1.
Antimalarial medicines were prescribed only to patients diagnosed
with malaria in both groups. This restricted prescription of ACT
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1,113 patients in the two groups received a prescription of
antimalarial drugs on day 0, of whom 1,097/1,113 (99%) were
prescribed artesunate+amodiaquine, whereas sulfadoxine-pyri-
methamine and quinine was given to six and ten patients,
respectively. There were apparent site differences in effect OR
(CD+RDT versus CD alone) of prescription rates, and testing for
homogeneity confirmed significant differences between sites.
Statistical multilevel modelling was thus used. RDT-aided
diagnosis was associated with statistically significantly lower
prescription of antimalarial treatment, 361/1,005 (36%) compared
with 752/882 (85%) in CD alone (OR 0.04, 95% CI 0.03–0.05,
p,0.001). The rate of antimalarial prescriptions in the CD+RDT
group was particularly low (16%) in patients above age15 y,
whereas the prescriptions rates were similar in all age categories of
CD-alone patients, ranging from 84% to 87% (Table 1).
A majority of antimalarial prescriptions were for children below
5 y, 228/361 (63%) in CD+RDT group and 423/752 (56%) in
CD alone group. Prescription in relation to microscopy results are
presented in Table 2.
Figure 1. Flow of patients through the trial.
doi:10.1371/journal.pmed.1000070.g001
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including mainly cotrimoxazole, but also ampicillin, amoxicillin,
and erythromycin. Prescription of antibiotics was significantly
higher in the CD+RDT than CD-alone group, 372/1,005 (37%)
and 235/882 (27%) (OR 1.8, 95%CI 1.5–2.2, p,0.001),
respectively (Table 2). The majority of antibiotics were prescribed
to children below age 5 y, 241/372 (65%) treatments in the
CD+RDT group and 178/235 (76%) in the CD-alone group.
Concomitant antibiotic and antimalarial treatment was prescribed
to 71/1,005 (7%) patients in the CD+RDT compared with 129/
882 (15%) in the CD-alone group. Antibiotics alone were
prescribed to 301/1,005 (30%) patients in the CD+RDT group
compared with 106/882 (12%) in the CD-alone group (OR 3.1,
95% CI 2.4–4.0, p,0.001). In the CD+RDT group 343/1,005
(34%) received neither antimalarial nor antibiotic treatment,
whereas this occurred in only 24/882 (3%) in the CD-alone group
(OR 21.4, 95% CI 13.9–33.1, p,0.001).
A total of 1,601/1,887 (85%) patients were prescribed
antipyretics, mainly paracetamol but also acetyl salicylic acid.
Antipyretics were prescribed to 87.0% versus 82.4% (OR 1.4,
95% CI 1.0–1.9, p=0.037) of patients in the CD+RDT and CD-
alone groups, respectively, but in similar proportions to all age
groups (CD+RDT 84%–88%, CD alone 79%–84%).
The general microscopy results are presented in Table 1. A total
of 552/1,887 (29%) blood slides were positive with a GM density
of 3,840 (range 16–457,236 and 95% CI 3,150–4,681) asexual
parasites/ml of blood. The results of CD+RDT and CD alone in
relation to BS results are presented in Table 3. Sensitivities,
specificities, and predictive values of both diagnostic methods are
presented in Table 4. Calculated RDT sensitivities were . 99%
for detecting a parasite density of $1,000 parasites/ml, 76% and
59% for parasite densities 100–999 and ,100 parasites/ml,
respectively, and thus generally 94% for $100 parasites/ml.
Antimalarial and antibiotic prescriptions in relation to age and
BS results are presented in Table 2. Among a total of 552 BS-
positive patients, 28 (14 children below age 5 y) were not
prescribed antimalarial treatment, 26 after CD+RDT (RDT
negative), and two after CD alone. Their parasite densities at
enrolment were, however, relatively low (GM 174 parasites/ml
Table 1. Proportions of fever patients diagnosed as malaria by age group according to CD+RDT, CD alone, and microscopy.
Diagnostic Test Age ,5 y Age 5–15 y Age .15 y Total
CD+RDT 228/544 (42%) 93/210 (44%) 40/251 (16%) 361/1,005 (36%)
CD alone 423/503 (84%) 169/196 (86%) 160/183 (87%) 752/882 (85%)
Microscopy 374/1,047 (36%) 128/406 (32%) 50/434 (12%) 552/1,887 (29%)
doi:10.1371/journal.pmed.1000070.t001
Table 2. Proportions of patients receiving antimalarial drugs and antibiotics in relation to day 0 microscopy results.
Drugs Received by Patients Diagnostic Testing Blood Slide Result ,5 years 5–15 years .15 years Total
Antimalarials CD+RDT BS positive 186/200 (93%) 71/72 (99%) 22/33 (67%) 279/305 (91%)
BS negative 42/344 (12%) 22/138 (16%) 18/218 (8%) 82/700 (12%)
CD alone BS positive 174/174 (100%) 54/56 (96%) 17/17 (100%) 245/247 (99%)
BS negative 249/329 (76%) 115/140 (82%) 143/166 (86%) 507/635 (80%)
Antibiotics CD+RDT BS positive 51/200 (26%) 4/72 (6%) 3/33 (9%) 58/305 (19%)
BS negative 190/344 (55%) 52/138 (38%) 72/218 (33%) 314/700 (45%)
CD alone BS positive 38/174 (22%) 4/56 (7%) 1/17 (6%) 43/247 (17%)
BS negative 140/329 (43%) 28/140 (20%) 24/166 (14%) 192/635 (30%)
doi:10.1371/journal.pmed.1000070.t002
Table 3. RDT and CD in relation to blood slide results in all
age groups combined.
Diagnostic Result
Blood Slide
Positive
Blood Slide
Negative Total
RDT positive 279 82 361
RDT negative 26 618 644
Total 305 700 1,005
CD positive 245 507 752
CD negative 2 128 130
Total 247 635 882
doi:10.1371/journal.pmed.1000070.t003
Table 4. Sensitivities, specificities, and positive and negative
predictive values in RDT and CD arms, respectively, in relation
to blood slide results.
Test Performance RDT CD
Sensitivity 92% .99%
Specificity 88% 20%
Positive predictive value 77% 33%
Negative predictive value 96% 98%
doi:10.1371/journal.pmed.1000070.t004
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total of 82/700 (12%) were prescribed antimalarial drugs in the
CD+RDT group (RDT positive) compared with 507/635 (80%) in
the CD-alone group (Table 2). A total of 82/361 (23%)
antimalarial treatments in the CD+RDT group and 507/635
(80%) in the CD-alone group may thus have been unnecessary
according to microscopy results (Tables 1 and 2). In contrast, BS-
negative patients received significantly more antibiotics in the
CD+RDT group, 314/700 (45%) patients compared with 192/
635 (30%) in the CD alone group (OR 2.1, 95%CI 1.6–2.6,
p,0.001) (Table 2).
The majority (1,813/1,887 [96%]) of patients returned for the
scheduled follow-up visit between 14 and 16 d after enrolment. The
remaining 74 patients were actively followed up by the research
team within three weeks. No deaths occurred during the study. A
totalof68patientsreturned tothehealth facilitybecauseofillhealth
during the 2-wk follow-up, mostly (51/68 [75%]) within the first
week. Of these 68 patients, 52 were children below age 5 y, nine
were 5–15 y old, and seven were adults. The rate of reattendance
due to perceived unsuccessful clinical cure was significantly lower in
the CD+RDT (25/1005 [2.5%]) than in the CD-alone group (43/
882 [4.9%]) (OR 0.5, 95% CI 0.3–0.9, p=0.005).
The BS collected at the time of reattendance were negative in
65/68 (96%) of these patients. The three positive slides, all from
the CD-alone group, had low densities: 64, 80, and 1,866
parasites/ml of blood. All three patients had initially been
prescribed ACT.
The health outcomes in patients with incorrect malaria
diagnoses, both false negative and false positive, are of particular
importance. Out of 28 patients (26 in CD+RDT and two in CD-
alone groups) with positive BS and not treated with antimalarial
drugs, only one returned because of any illness during the two-
week follow-up, carrying a low density of 32 parasites/ml of blood.
On day 14, an additional four of 28 patients were found to be still
BS positive (32, 85, 360, and 47,065 parasites/ml). Among 549
patients having negative BS but clinically diagnosed and treated
for malaria, only 20 (3.6%) returned to the health facility with
persistent symptoms.
Of 1,113 patients treated for malaria in both groups, 42 (3.8%)
returned with illness, compared with 26/773 (3.4%) who did not
receive antimalarial treatment. Among patients with positive BS
on day 0 and treated for malaria, the frequencies of positive slides
on routine follow-up between days 14 and 16 were similar in the
two groups, 39/279 (14%) in the CD+RDT and 38/245 (16%) in
the CD-alone group. The overall malaria treatment failure after
nonsupervised drug intake was thus 77/524 (15%) on day 14, with
a GM of 611 (range 16–34,500) parasites/ml.
The mean total costs per patient by age group are presented in
Table 5. They include costs of transport, consultation, RDT, and
treatment at study inclusion and at reattendance during follow-up
period because of illness. Overall, adding RDTs became cost
saving in patients above15 y, when malaria treatment is reduced to
less than 20% of fever patients.
Discussion
We found an overall 2-fold reduction in prescription of
antimalarial drugs and reattendance of patients due to illness
during the two-week follow-up period in the CD+RDT group
compared with CD-alone group. Overall costs were, however,
similar in the two groups despite a significant reduction of cost
among the adult patients after RDT-aided diagnosis.
Almost all enrolled fever patients in the CD-alone arm were
considered and treated as malaria patients, resulting in high
diagnostic sensitivity (99%) but low specificity (20%). This result
follows the suggestion that fever alone may be a better criterion for
malaria treatment than more complicated algorithms [4]. Studies
on clinical diagnostic algorithms have shown that with weighting
and scoring systems for clinical signs and symptoms may result in
sensitivities of 70%–88% and specificities of 63%–82%
[3,4,17,27]. However, these methods may be too complicated to
be effective under operational conditions, and the algorithms may
be site- and context-specific [4].
Health workers learnt to use RDTs correctly with relative ease,
confirming that the tests are simple to perform and interpret [11].
The estimated sensitivity (.100 parasites/ml of blood) is in line with
WHO recommendations [10] and is also in accordance with a
recentreviewconcludingthat the accuracies oftheHRP2-basedtest
in P. falciparum–endemic areas are normally high with a mean
sensitivity of 93% [13]. The specificity in our study—88%—was
similar to or lower than in some previous studies [12,13,15,16,19].
Especially under field conditions, heat and time stability could be an
important impediment for the optimal use of RDTs for malaria, but
according to the manufacturer Parachek Pf is expected to be stable
at temperatures up to 40uC for up to two years.
The use of confirmatory malaria diagnosis with RDT is
expected to reduce the overuse of antimalarial drugs by ensuring
that treatment is targeted to patients suffering from malaria
infections as opposed to treating all patients with fever. Our
findings confirm this expectation, although the impact of RDT-
aided diagnosis will obviously be highly dependent on the malaria
incidence (prevalence of malaria in fever patients) in a given
situation.
Importantly, in our study, the study nurses showed great
confidence in the RDT results as a guide to choice of treatment, as
did the patients. This is in contrast to the assumption that care
providers, although willing to perform diagnostic tests, do not
always comply with the results, especially when the result is
negative [15,20]. High adherence by prescribers in relation to
RDT results was, however, also reported in a recent study
conducted in mainland Tanzania [28]. We believe that the high
compliance and confidence in the RDT in our study may result
from a successful pre-study training, although local beliefs,
behaviours, and treatment traditions may also account for
Table 5. Mean total costs (USD) per patient by age group in
CD+RDT and CD alone groups, respectively.
Group Costs ,5 y 5–15 y .15 y All ages
CD+RDT
group
General costs 1.90 1.90 1.90 1.90
Drugs 0.39 0.63 0.69 0.51
Reattendance 0.08 0.06 0.03 0.06
Total mean costs 2.37 2.59 2.62 2.47
CD alone
group
General costs 1.40 1.40 1.40 1.40
Drugs 0.58 0.89 1.55 0.85
Reattendance 0.17 0.05 0.05 0.12
Total mean costs 2.15 2.34 3.00 2.37
All estimates are based on an exchange rate of USD 1=TSh 1,100. General
costs=transport (USD 0.90)+consultation (USD 0.50)+RDT (USD 0.50)=USD
1.90. Drugs=ACT (USD 0.5021.40)+antibiotics USD (0.3020.90)+antipyretics
(USD 0.0520.20). Reattendance costs=transport (USD 0.90)+consultation (USD
0.50)+drugs (ACT, antibiotic+antipyretics=average USD 1.10)=USD 2.50.
doi:10.1371/journal.pmed.1000070.t005
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tions [15,20]. We further realise that the study situation,
supervision, and incentives provided to the nurses may also affect
compliance, but we do not believe it has seriously biased our
results. The incentive to the nurses was consistent with common
practice for project participation in Zanzibar, but whereas it
represented up to approximately a 65% increment of the ordinary
salary it was not influenced or affected by performance. Our
results obviously need to be confirmed before RDT can be more
generally recommended, but we do believe they suggest that RDT
use may be efficient if local diagnostic and treatment traditions are
properly addressed.
Fearing false negative test results and being aware that delays in
providing effective treatment can be fatal for malaria patients is
reported to be the main reason to prescribe antimalarial drugs
despite a negative RDT result. Importantly, in our study, the
patients with malaria detected by BS but non-detectable by RDT
and therefore not treated with antimalarial drugs had relatively
low parasite densities and no patients developed any severe
malaria manifestations during the two week follow-up. This
supports a general recommendation of consistence in not treating
RDT negative patients. Re-testing will, however, obviously be
required if the illness remains or aggravates.
Our finding of a reduction in perceived illness during a two-
week follow-up in the CD+RDT group of patients is critical. This
was probably attributed to improved treatment of patients with
fever not associated with malaria. More antibiotics were
prescribed to the RDT-negative patients. The introduction of
RDT and ACT thus provides an opportunity to improve the
treatment of both malaria and bacterial diseases.
We did consider the potential selection bias of the four health
facilities; indeed, significant heterogeneity was observed with
regard to the primary effect parameter. We do, however, assume
this heterogeneity was at least partly accounted for by multilevel
analysis and, since the RDT effect on drug prescriptions was quite
large in each PHCU, it seems unlikely to be due to selection bias.
The selection of the four study sites was done to provide a
relatively representative picture of both malaria epidemiology and
previous use of RDT in Zanzibar. Since RDTs had already been
introduced by MSF in some parts of Zanzibar we opted for
including PHCUs both with previous experience (two sites) and
without previous RDT use (two sites). Beside the previous RDT
exposure, the selection of the four study sites was based on
representing a common rural situation and representing both of
the two major islands in Zanzibar, i.e. Unguja and Pemba (two
PHCUs on each island). However, we do of course acknowledge
that the choice of the four sites remains arbitrary and of low
number and thus cannot be fully representative of an overall
Zanzibar situation and even less so of an overall situation in sub-
Saharan Africa, which indeed is very diverse itself with regard to
epidemiology of malaria, cultural and behavioural aspects, health
care structure, etc.
With the understanding that four PHCUs is a very low number,
we used a cross-over design of RDT versus non-RDT weeks within
sites. The choice of RDT or non-RDT the first week was based on
an allocation with one previous MSF/RDT site being in either arm
and one non previous MSF/RDT similarly being in either arm.
Still, we acknowledge that there may still be confounding effects
with regard to health-seeking behaviour or even selection bias by
study nurses on respective weeks by (a) patients/caretakers
postponing health care attendance to a week with RDT or staff
applying exclusion criteria on a CD week and instead request the
patient to return on a RDT week, and/or (b) attending alternate
PHCUs where RDT is performed. However, we assume that (a) is
less realistic, considering that uncomplicated malaria requires
urgent treatment and patients or their caretakers as well as health
careworkersarethereforenotlikelytowait and postponetreatment.
We also do not believe (b) is realistic because systematic RDT use
was not implemented outside study PHCUs at the time of the trial
and the study sites were located far from each other. And indeed
statistical analysis showed no significant difference between
frequencies of fever patient attendance on RDT and non-RDT
weeks. The only trend observed with regard to frequency of
attendance was a tendency to a relative increase toward the later
periodofthe study,compatiblewithincreased malaria transmission.
In summary, RDTs were well performed in peripheral health
facilities with acceptable sensitivity and specificity for identifying
malaria-attributable fever episodes. The RDT results were
adhered to and did provide consistent and significant reduction
in antimalarial treatment in parallel with an increase in prescribed
antibiotics. This probably contributed to the significant reduction
in reattendance due to illness during the two-week follow-up. Our
results indicate that RDTs may represent an important tool for
improved management of fever patients in peripheral health care
settings in malaria-endemic areas, especially where ACT has been
introduced for treatment of uncomplicated malaria.
Supporting Information
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Background. Every year, nearly one million people (mainly
children living in sub-Saharan Africa) die because of malaria,
a subtropical and tropical parasitic disease. Although several
parasites cause malaria, Plasmodium falciparum is
responsible for most of these deaths. Indeed, infection
with P. falciparum can be fatal within hours if left untreated.
For the past 50 years, the main treatments for P. falciparum
malaria have been chloroquine and sulfadoxine/
pyrimethamine. Unfortunately, parasitic resistance to both
of these ‘‘monotherapies’’ is now widespread and the illness
and death caused by P. falciparum in sub-Saharan Africa and
elsewhere has been increasing. To combat this increase, the
World Health Organization now recommends artemisinin
combination therapy (ACT) for P. falciparum malaria in all
regions with drug-resistant malaria. In ACT, artemisinin
derivatives (new, fast-acting antimalarial drugs) are used in
combination with another antimalarial to reduce the chances
of P. falciparum becoming resistant to either drug.
Why Was This Study Done? The chances of P. falciparum
becoming resistant to ACT should also be reduced by giving
ACT only to people who definitely have malaria.
Unfortunately, many people who do not have malaria are
given ACT because symptom-based (clinical) diagnosis
cannot always distinguish between patients whose fever is
caused by malaria and those who have a different infection
and who would, therefore, gain more benefit from other
treatments. Microscopic detection of parasites in blood
smears would greatly improve the accuracy of malaria
diagnosis, but this test is rarely available in rural clinics in
developing countries. Might the recently developed ‘‘rapid
diagnostic tests’’ (RDTs) for P. falciparum provide an
alternative way to improve malaria diagnosis and thus
reduce the overuse of ACT? In this ‘‘cross-over trial,’’ the
researchers investigate the effect of the routine use of an
RDT for the diagnosis of malaria on ACT prescribing, health
outcomes, and costs in four primary health-care clinics in
Zanzibar (part of the United Republic of Tanzania), one of the
first regions in sub-Saharan Africa to introduce ACT.
What Did the Researchers Do and Find? Each clinic
used RDT-aided symptom-based clinical diagnosis of malaria
(the RDT arm of the trial) and symptom-based clinical
diagnosis (the CD arm) in alternate weeks to decide whether
patients attending with fever had malaria. ACT was
prescribed to everyone diagnosed with malaria; during RDT
weeks only patients with positive RDT results were
prescribed ACT. During the trial, 36% of the 1,005 patients
in the RDT arm were prescribed ACT compared to 85% of the
882 patients in the CD arm. 37% and 27% of the RDT and CD
arm patients, respectively, were prescribed antibiotics and
fewer RDT-arm patients than CD-arm patients returned to
the clinic because they still felt ill. The overall cost per patient
was similar in both arms. The researchers also report that
23% of the antimalarial treatments given to patients in the
RDT arm and 80% of those given to patients in the CD arm
were given to people with no microscopically detectable
parasites in their blood. Importantly, none of the 26 patients
in the RDT group who had positive smears but who were not
treated with antimalarial drugs because of a negative RDT
result developed severe malaria.
What Do These Findings Mean? These findings suggest
that the replacement of clinical diagnosis alone with RDT-
aided diagnosis may reduce the number of people
prescribed ACT who do not have malaria and may increase
the number of patients given antibiotics for nonmalarial
illnesses without increasing costs. However, while the health-
care workers involved in this study only prescribed ACT to
those patients in the RDT arm who had a positive RDT result
(as stipulated in the trial protocol), evidence from other
studies suggests that health-care workers often give
antimalarials to patients with negative RDT results.
Consequently, these findings may not be generalizable to
other clinics. Nevertheless, it is reassuring that none of the
patients who had malaria that was detected by blood smear
but that was missed by RDT subsequently developed severe
malaria. This finding, if replicated, might persuade health-
care workers to trust RDT results rather than prescribing ACT
to everyone with a fever ‘‘just in case.’’
Additional Information. Please access these Web sites via
the online version of this summary at http://dx.doi.org/10.
1371/journal.pmed.1000070.
N This study is further discussed in a PLoS Medicine
Perspective by Zeno Bisoffi and colleagues
N The MedlinePlus encyclopedia contains a page on malaria
(in English and Spanish)
N Information is available from the World Health Organiza-
tion on malaria (in several languages) and on rapid
diagnostic tests for malaria. Their 2008 World Malaria
Report includes information about global efforts to control
malaria and the latest information on malaria in the United
Republic of Tanzania
N The US Centers for Disease Control and Prevention provide
information on malaria (in English and Spanish)
N Information is available from the Roll Back Malaria
Partnership on its approach to the global control of
malaria and on artemisinin-based combination therapies
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